This chapter will discuss workup, treatment, and management of esophageal cancer with focus on radiotherapy studies and techniques.
KeywordsEsophageal cancer Squamous cell carcinoma Adenocarcinoma Radiotherapy
We thank Charlotte Dai Kubicky MD, PhD, and Marc B. Nash MD for their work on the prior edition of this chapter.
- Adelstein DJ, Rice TW, Rybicki LA, et al. Mature Results from a Phase II Trial of Postoperative Concurrent Chemoradiotherapy for Poor Prognosis Cancer of the Esophagus and Gastroesophageal Junction.J Thor Oncol. 2009;4(10):1264–69.Google Scholar
- Bang Y-J, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 2010;376:687–97.CrossRefPubMedGoogle Scholar
- Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol. 2006;17:827–34.CrossRefPubMedGoogle Scholar
- Gaspar LE, Winter K, Kocha WI, Coia LR, Herskovic A, Graham M. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (radiation therapy oncology Group study 9207): final report. Cancer. 2000;88:988–95.CrossRefPubMedGoogle Scholar
- Lee J, Lim D-H, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30:268–73.CrossRefPubMedGoogle Scholar
- Penniment MG, Harvey JA, Wong R, et al. A randomized phase III study in advanced esophageal cancer (OC) to compare the quality of life (QoL) and palliation of dysphagia in patients treated with radiotherapy (RT) or chemoradiotherapy (CRT) TROG 03.01 NCIC CTG ES.2. J Clin Oncol. 2015;33(suppl 3; abstr 6)Google Scholar